The effect of favipiravir versus hydroxychloroquine on clinical and laboratory findings in COVID-19 in healthcare workers.

Turan, Derya Bayirli; Mentes, Mehtap; Özel, Yildiran; Serefhanoglu, Kivanç; Aydogan, Burcu; Ibil, Nese; Günesdogdu, Füsun; Orucova, Hijran Mammadova; Saltürk, Cüneyt; Çelik, Hakan

Turan, Derya Bayirli; Mentes, Mehtap; Özel, Yildiran; Serefhanoglu, Kivanç; Aydogan, Burcu; Ibil, Nese; Günesdogdu, Füsun; Orucova, Hijran Mammadova; Saltürk, Cüneyt; Çelik, Hakan.

Afiliação

Turan DB; Department of Infectious Diseases and Clinical Microbiology, Istanbul Yeni Yüzyil University Faculty of Medicine, Istanbul, Turkey. Electronic address: deryabturan@gmail.com.
Mentes M; Department of Occupational Health and Safety, Istanbul Yeni Yüzyil University Faculty of Medicine, Istanbul, Turkey.
Özel Y; Department of Occupational Health and Safety, Istanbul Yeni Yüzyil University Faculty of Medicine, Istanbul, Turkey.
Serefhanoglu K; Department of Infectious Diseases and Clinical Microbiology, Istanbul Yeni Yüzyil University Faculty of Medicine, Istanbul, Turkey.
Aydogan B; Department of Infection Control Committee, Istanbul Yeni Yüzyil University Faculty of Medicine, Istanbul, Turkey.
Ibil N; Department of Infection Control Committee, Istanbul Yeni Yüzyil University Faculty of Medicine, Istanbul, Turkey.
Günesdogdu F; Department of Family Medicine, Istanbul Yeni Yüzyil University Faculty of Medicine, Istanbul, Turkey.
Orucova HM; Department of Chest Diseases, Istanbul Yeni Yüzyil University Faculty of Medicine, Istanbul, Turkey.
Saltürk C; Department of Chest Diseases, Istanbul Yeni Yüzyil University Faculty of Medicine, Istanbul, Turkey.
Çelik H; Department of Pharmacology, Istanbul Yeni Yüzyil University Faculty of Medicine, Istanbul, Turkey.

Braz J Infect Dis ; 26(1): 102328, 2022.

Article em En | MEDLINE | ID: mdl-35139366

Assuntos

Tratamento Farmacológico da COVID-19; Hidroxicloroquina; Adulto; Amidas; Antivirais/efeitos adversos; Pessoal de Saúde; Humanos; Hidroxicloroquina/efeitos adversos; Laboratórios; Pirazinas; SARS-CoV-2; Resultado do Tratamento; Adulto Jovem

Palavras-chave

COVID-19; Favipiravir; Healthcare workers; Hydroxychloroquine; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Hidroxicloroquina Tipo de estudo: Diagnostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google